Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC) (Q83031882)
Jump to navigation
Jump to search
scientific article published on 01 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC) |
scientific article published on 01 January 2009 |
Statements
Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC) (English)
Elaine H Lim
Shen-Li Zhang
Jia-Liang Li
Wee-See Yap
Tse-Chiang Howe
Bien-Peng Tan
Yong-Shyan Lee
Daniel Wong
Kay-Leong Khoo
Kar-Yin Seto
Lenny Tan
Thirugananam Agasthian
Heng-Nung Koong
John Tam
Christie Tan
Michael Caleb
Alex Chang
Alan Ng
1 January 2009